These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

158 related articles for article (PubMed ID: 24571671)

  • 81. Air Drep-A Retrospective Study Evaluating the Influence of Weather Conditions and Viral Epidemics on Vaso-Occlusive Crises in Patients with Sickle Cell Disease Living in French Guiana.
    Parriault MC; Cropet C; Fahrasmane A; Rogier S; Parisot M; Nacher M; Elenga N
    Int J Environ Res Public Health; 2019 Jul; 16(15):. PubMed ID: 31370136
    [TBL] [Abstract][Full Text] [Related]  

  • 82. Intravenous morphine pharmacokinetics in pediatric patients with sickle cell disease.
    Dampier CD; Setty BN; Logan J; Ioli JG; Dean R
    J Pediatr; 1995 Mar; 126(3):461-7. PubMed ID: 7869211
    [TBL] [Abstract][Full Text] [Related]  

  • 83. Improving the Care of Individuals With Sickle Cell Disease in the Emergency Department Using a Quality Improvement Framework: The Emergency Department Sickle Cell Assessment of Needs and Strengths (ED-SCANS).
    Brennan-Cook J; Bonnabeau E; Harris-Bloom H; Tanabe P
    Adv Emerg Nurs J; 2019; 41(3):261-270. PubMed ID: 31356252
    [TBL] [Abstract][Full Text] [Related]  

  • 84. Evaluation of Intravenous Diphenhydramine Use in Patients with Sickle Cell Vaso-Occlusive Crisis.
    Rector K; Merchant S; Crawford R; Arnall JR; Symanowski J; Veeramreddy P; Osunkwo I
    Hosp Pharm; 2021 Dec; 56(6):725-728. PubMed ID: 34732930
    [No Abstract]   [Full Text] [Related]  

  • 85. Breathing patterns during vaso-occlusive crisis of sickle cell disease.
    Needleman JP; Benjamin LJ; Sykes JA; Aldrich TK
    Chest; 2002 Jul; 122(1):43-6. PubMed ID: 12114337
    [TBL] [Abstract][Full Text] [Related]  

  • 86. Lidocaine and Ketamine Infusions as Adjunctive Pain Management Therapy: A Retrospective Analysis of Clinical Outcomes in Hospitalized Patients Admitted for Pain Related to Sickle Cell Disease.
    Zavala NA; Knoebel RW; Anitescu M
    Front Pain Res (Lausanne); 2022; 3():878985. PubMed ID: 35992021
    [TBL] [Abstract][Full Text] [Related]  

  • 87. Variations in pediatric emergency medicine physician practices for intravenous fluid management in children with sickle cell disease and vaso-occlusive pain: A single institution experience.
    Carden MA; Patil P; Ahmad ME; Lam WA; Joiner CH; Morris CR
    Pediatr Blood Cancer; 2018 Jan; 65(1):. PubMed ID: 28766843
    [No Abstract]   [Full Text] [Related]  

  • 88. Opioid Use in Vaso-Occlusive Crisis During Intravenous Opioid Drug Shortage.
    Katsivalis KV; Kosacz J; Austin Szwak J
    Hosp Pharm; 2022 Dec; 57(6):721-726. PubMed ID: 36340631
    [No Abstract]   [Full Text] [Related]  

  • 89. Intravenous Acetaminophen For the Management of Pain During Vaso-occlusive Crises in Pediatric Patients.
    Baichoo P; Asuncion A; El-Chaar G
    P T; 2019 Jan; 44(1):5-8. PubMed ID: 30675085
    [TBL] [Abstract][Full Text] [Related]  

  • 90. Subdissociative-dose ketamine for sickle cell vaso-occlusive crisis: a narrative review for the emergency physician.
    Bawany MH; Motov SM
    Clin Exp Emerg Med; 2022 Sep; 9(3):169-175. PubMed ID: 36168777
    [TBL] [Abstract][Full Text] [Related]  

  • 91. Assessment of patient-controlled analgesia versus intermittent opioid therapy to manage sickle-cell disease vaso-occlusive crisis in adult patients.
    Al-Anazi A; Al-Swaidan L; Al-Ammari M; Al-Debasi T; Alkatheri AM; Al-Harbi S; Obaidat AA; Al-Bekairy AM
    Saudi J Anaesth; 2017; 11(4):437-441. PubMed ID: 29033725
    [TBL] [Abstract][Full Text] [Related]  

  • 92. Patient-Controlled Analgesia vs Intravenous Push Hydromorphone for Pain Management of Vaso-Occlusive Crisis Associated With Sickle Cell Disease.
    Russo K; Chhunchha P
    J Pain Palliat Care Pharmacother; 2023 Jun; 37(2):116-122. PubMed ID: 36701332
    [TBL] [Abstract][Full Text] [Related]  

  • 93. Evaluation of a Non-Parenteral Opioid Analgesia Protocol for Acute Sickle Cell Pain Episodes in Children.
    Telfer P; Barroso F; Newell K; Challands J; Kaya B
    J Clin Med; 2019 Oct; 8(10):. PubMed ID: 31635344
    [TBL] [Abstract][Full Text] [Related]  

  • 94. Management of acute chest wall sickle cell pain with nebulized morphine.
    Ballas SK; Viscusi ER; Epstein KR
    Am J Hematol; 2004 Jun; 76(2):190-1. PubMed ID: 15164390
    [TBL] [Abstract][Full Text] [Related]  

  • 95. Evaluation of a clinical protocol using intranasal fentanyl for treatment of vaso-occlusive crisis in sickle cell patients in the emergency department.
    Paquin H; Trottier ED; Pastore Y; Robitaille N; Dore Bergeron MJ; Bailey B
    Paediatr Child Health; 2020 Aug; 25(5):293-299. PubMed ID: 32765165
    [TBL] [Abstract][Full Text] [Related]  

  • 96. Pathophysiology and principles of management of the many faces of the acute vaso-occlusive crisis in patients with sickle cell disease.
    Ballas SK
    Eur J Haematol; 2015 Aug; 95(2):113-23. PubMed ID: 25288149
    [TBL] [Abstract][Full Text] [Related]  

  • 97. Clinical Utility of Neutrophil to Lymphocyte Ratio in Sickle Cell Disease With Vaso-Occlusive Crisis.
    Maharaj S; Chang S
    Hematol Oncol Stem Cell Ther; 2023 Jan; 16(1):79-82. PubMed ID: 36634279
    [TBL] [Abstract][Full Text] [Related]  

  • 98. Patient-controlled analgesia in sickle-cell disease painful vaso-occlusive crises: should we add ketamine to morphine?
    Zuccarini F; Aoragh A; Maggiore A; Veliziotis I; Kapessidou P
    Minerva Anestesiol; 2021 Oct; 87(10):1146-1147. PubMed ID: 33853280
    [No Abstract]   [Full Text] [Related]  

  • 99. Intravenous Fluid Administration and the Risk of Adverse Outcomes in Sickle Cell Disease Patients Hospitalized for Vaso-Occlusive Crisis.
    Ojo AS; Ojukwu S; Asmare W; Odipe O; Larbi D
    J Hematol; 2022 Oct; 11(5):159-166. PubMed ID: 36406833
    [TBL] [Abstract][Full Text] [Related]  

  • 100. Clinical Pathway for Vaso-Occlusive Pain Reduces Hospital Admissions.
    Jones W; Jang A; Myers L; Dasgupta A; DeBord J
    J Healthc Qual; 2022 Jan-Feb 01; 44(1):50-58. PubMed ID: 34965539
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.